Invention Grant
- Patent Title: Therapeutic uses for VEGFR1 antibodies
-
Application No.: US14203675Application Date: 2014-03-11
-
Publication No.: US09670284B2Publication Date: 2017-06-06
- Inventor: Zhonghua Qi , Matthew Douglas Breyer , Ling Liu
- Applicant: ELI LILLY AND COMPANY
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Jennifer K. Gregory; Matthew T. Lord
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to methods of using VEGFR1 antibodies for the treatment of chronic kidney disease.
Public/Granted literature
- US20140271675A1 THERAPEUTIC USES FOR VEGFR1 ANTIBODIES Public/Granted day:2014-09-18
Information query
